Sage Journals: Discover world-class research

Abstract

View all access options for this article.

Batty

D.S.

Jr. , Swanson

S.J.

, Kirk

A.D.

, Ko

C.W.

, Agodoa

L.Y.

, Abbott

K.C.

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival.

Am J Transplant 2001; 1: 179–84.

Bloom

R.D.

, Lake

J.R.

Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients.

Am J Transplant 2006; 6: 2232–7.

Kamar

, Rostaing

, Selves

. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005; 5: 1704–12.

Baid

, Tolkoff-Rubin

, Saidman

. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant 2003; 3: 74–8.

Abbott

K.C.

, Bucci

J.R.

, Matsumoto

C.S.

. Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003; 14: 2908–18.

Lake

J.R.

The role of immunosuppression in recurrence of hepatitis C.

Liver Transpl 2003; 9(suppl): S63–6.